表紙:吸入・経鼻製品受託製造サービスプロバイダーの世界市場-規模・シェア・動向分析:ドラッグデリバリー製品別(定量吸入器、粉末吸入器、ネブライザー)、サービス別、地域別、セグメント予測(2023年~2030年)
市場調査レポート
商品コード
1170990

吸入・経鼻製品受託製造サービスプロバイダーの世界市場-規模・シェア・動向分析:ドラッグデリバリー製品別(定量吸入器、粉末吸入器、ネブライザー)、サービス別、地域別、セグメント予測(2023年~2030年)

Inhaled And Intranasal Products Contract Service Providers Market Size, Share & Trends Analysis Report By Drug Delivery Product (Metered-dose inhalers, Dry powder inhalers, Nebulizers), By Services, By Region And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 275 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
吸入・経鼻製品受託製造サービスプロバイダーの世界市場-規模・シェア・動向分析:ドラッグデリバリー製品別(定量吸入器、粉末吸入器、ネブライザー)、サービス別、地域別、セグメント予測(2023年~2030年)
出版日: 2022年11月15日
発行: Grand View Research
ページ情報: 英文 275 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の吸入・経鼻製品受託製造サービスプロバイダーの市場規模は、2023年から2030年までに8.5%のCAGRで成長し、2030年に45億米ドルに達すると予測されています。

開発および製品設計の進歩によりドラッグデリバリーシステムが改善されたこと、医療機器のコスト削減を重視するメーカーの増加は、市場の成長を促進しています。

当レポートでは、世界の吸入・経鼻製品受託製造サービスプロバイダー市場について調査しており、市場展望、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • ドラッグデリバリー製品
    • サービス
    • 地域範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 2次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析(モデル1)
    • 数量価格分析(モデル2)
  • 2次情報のリスト
  • 1次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場展望

第3章 吸入・経鼻製品受託製造サービスプロバイダーの市場変数、動向、および範囲

  • 市場系列展望
    • 親会社の市場展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
      • COPDなどの慢性疾患の有病率の上昇、糖尿病の有病率の増加
      • 高齢者人口の増加
      • 製品オファリングに関する技術進歩の増加
    • 市場抑制要因分析
      • 製品承認のための厳しい政府規制
    • COVID-19の影響と回復の分析
    • ヒートマップ分析
    • 主要取引と戦略的提携分析
    • 業界分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 吸入・経鼻製品受託製造サービスプロバイダー市場:ドラッグデリバリー製品セグメント分析

  • 吸入・経鼻製品受託製造サービスプロバイダー市場:定義と範囲
  • 吸入・経鼻製品受託製造サービスプロバイダー市場:ドラッグデリバリー製品の市場シェア分析(2022年および2030年)
    • 定量吸入器
    • 粉末吸入器
    • ネブライザー
    • その他

第5章 吸入・経鼻製品受託製造サービスプロバイダー市場:サービスセグメント分析

  • 吸入・経鼻製品受託製造サービスプロバイダー市場:定義と範囲
  • 吸入・経鼻製品受託製造サービスプロバイダー市場:サービスの市場シェア分析(2022年および2030年)
    • 品質保証
    • 薬事サービス
    • 製品の設計と開発
    • 製品の試験と滅菌
    • 製品の実装
    • 製品のアップグレード
    • 製品のメンテナンス
    • 受託製造

第6章 吸入・経鼻製品受託製造サービスプロバイダー市場:地域分析

  • 吸入・経鼻製品受託製造サービスプロバイダー:地域の市場シェア分析(2022年および2030年)
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • デンマーク
      • デンマークの吸入・経鼻製品受託製造サービスプロバイダー市場(100万米ドル)(2018年~2030年)
    • スウェーデン
      • スウェーデンの吸入・経鼻製品受託製造サービスプロバイダー市場(100万米ドル)(2018年~2030年)
    • ノルウェー
      • ノルウェーの吸入・経鼻製品受託製造サービスプロバイダー市場(100万米ドル)(2018年~2030年)
    • その他のEU
      • その他のEUの吸入・経鼻製品受託製造サービスプロバイダー市場(100万米ドル)(2018年~2030年)
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • タイ
    • 韓国
    • その他のアジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • 南アラビア
    • アラブ首長国連邦
    • クウェート
    • その他の中東・アフリカ

第7章 競合情勢

  • 吸入・経鼻製品受託製造サービスプロバイダー:企業市場シェア分析(2022年および2030年)
  • 企業プロファイル
    • Lonza
    • Catalent
    • Kindeva Drug Delivery(旧3M Drug Delivery Systems)
    • Recipharma
    • Quotient Services
    • Hovione
    • Colep
    • Beximo Pharmaceuticals
    • DPT Laboratories
    • Orion
図表

List of Tables

  • Table 1 List of Secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Inhaled and Intranasal products contract service providers market snapshot (2022)
  • Fig. 10 Inhaled and Intranasal products contract service providers market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Inhaled and Intranasal Products Contract Service Providers market drug delivery product outlook: Segment dashboard
  • Fig. 20 Inhaled and Intranasal Products Contract Service Providers market: drug delivery product movement analysis
  • Fig. 21 Metered- dose inhalers market, 2018 - 2030 (USD Million)
  • Fig. 22 Dry powder inhalers market, 2018 - 2030 (USD Million)
  • Fig. 23 Nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Inhaled and Intranasal Products Contract Service Providers market services outlook: Segment dashboard
  • Fig. 26 Inhaled and Intranasal Products Contract Service Providers market: services movement analysis
  • Fig. 27 Quality Assurance market, 2018 - 2030 (USD Million)
  • Fig. 28 Regulatory Affair Services market, 2018 - 2030 (USD Million)
  • Fig. 29 Product Design & Development market, 2018 - 2030 (USD Million)
  • Fig. 30 Product Testing & Sterilization market, 2018 - 2030 (USD Million)
  • Fig. 31 Product Implementation market, 2018 - 2030 (USD Million)
  • Fig. 32 Product Upgrade market, 2018 - 2030 (USD Million)
  • Fig. 33 Product Maintenance market, 2018 - 2030 (USD Million)
  • Fig. 34 Contract Manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional market: Key takeaways
  • Fig. 36 Inhaled and Intranasal Products Contract Service Providers market: Regional movement analysis
  • Fig. 37 North America. market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market, 2018 - 2030 (USD Million)
  • Fig. 41 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany market, 2018 - 2030 (USD Million)
  • Fig. 43 France market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market, 2018 - 2030 (USD Million)
  • Fig. 49 Rest of EU market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market, 2018 - 2030 (USD Million)
  • Fig. 52 China market, 2018 - 2030 (USD Million)
  • Fig. 53 India market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 57 Rest of APAC market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 62 Rest of LATAM market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait market, 2018 - 2030 (USD Million)
  • Fig. 68 Rest of MEA market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-001-3

Inhaled And Intranasal Products Contract Service Providers Market Growth & Trends:

The global inhaled and intranasal products contract service providers market size is estimated to reach USD 4.5 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.5% from 2023 to 2030. There is an increased awareness of the effective and advanced respiratory devices compared to the traditional treatments fueling the growth of the market.

Inhaler design has seen little change in the past ten years, but some features have led to advancements that open new possibilities for disease treatment according to an article published by the National Library of Medicine (NIH) in 2021. The development of vibrating mesh systems for nebulizers was the most significant advancement, whereas the formulation, metering system, and aerosol dispersion properties are the three main components of dry powder inhaler technology. Furthermore, one of the most important breakthroughs at the start of the new millennium was the regulatory approval and commercialization of Advair/Seretide (GlaxoSmithKline). These developments and advancements in the design of the product improve the drug delivery system. Hence, contributing to the growth of the inhaled & intranasal products contract service providers market.

COVID-19 has resulted in a positive impact on the market. For instance, according to a July 2020 article titled "Inhalers Safe During COVID-19 Pandemic," asthma and chronic obstructive pulmonary disease patients are usually prescribed inhaled and oral corticosteroids along with inhalers to avoid attacks. Inhaler shortages occurred in the U.K. as a result of a 400% increase in demand during the pandemic. The U.K.'s population was attempting to stock up in anticipation of the COVID-19 pandemic, according to the Department of Health and Social Care, which resulted in distressing shortages. As a result, during the pandemic phase, such incidences increased the demand for the market.

Inhaled And Intranasal Products Contract Service Providers Market Report Highlights:

  • Metered- dose inhalers (MDIs) segment dominated the market with a revenue share of 50.6% in 2022. This is due to the rise in their ease of use, which is often self-administered by the patient through inhalation in short bursts of a predetermined dose
  • Based on services, contract manufacturing dominated the segment with a revenue share of 54.8% in 2022. The increasing focus of manufacturers on reducing the cost of medical devices drives the growth of the market
  • Quality assurance services is anticipated to register the fastest CAGR growth of 10.8% during the forecast period
  • Asia Pacific dominated the market in 2022 with a 41.7% market share. The presence of a large number of contract manufacturers, and increasing respiratory diseases such as COPD are the key factors driving the growth of the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Drug Delivery Product
    • 1.1.2. Services
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Inhaled and Intranasal Products Contract Service Providers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic diseases such as COPD, increasing prevalence of diabetes
      • 3.2.1.2. Rise in geriatric population
      • 3.2.1.3. Increase in technological advancement w.r.t to product offerings
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Government Regulations for the Product Approval
    • 3.2.3. Covid-19 Impact & Recovery Analysis
    • 3.2.4. Heat Map Analysis
    • 3.2.5. Major Deals and Strategic Alliances Analysis
    • 3.2.6. Industry Analysis - Porter's
    • 3.2.7. PESTLE Analysis

Chapter 4. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Segment Analysis

  • 4.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
  • 4.2. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Market Share Analysis, 2022 & 2030
    • 4.2.1. Metered- dose Inhalers
      • 4.2.1.1. Metered- dose Inhalers Market, 2018 - 2030 (USD Million)
    • 4.2.2. Dry Powder Inhalers
      • 4.2.2.1. Dry Powder Inhalers Market, 2018 - 2030 (USD Million)
    • 4.2.3. Nebulizers
      • 4.2.3.1. Nebulizers Market, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Inhaled and Intranasal Products Contract Service Providers Market: Services Segment Analysis

  • 5.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
  • 5.2. Inhaled and Intranasal Products Contract Service Providers Market: Services Market Share Analysis, 2022 & 2030
    • 5.2.1. Quality Assurance
      • 5.2.1.1. Quality Assurance Market, 2018 - 2030 (USD Million)
    • 5.2.2. Regulatory Affairs Services
      • 5.2.2.1. Regulatory Affairs Services Market, 2018 - 2030 (USD Million)
    • 5.2.3. Product Design & Development
      • 5.2.3.1. Product Design & Development Market, 2018 - 2030 (USD Million)
    • 5.2.4. Product Testing & Sterilization
      • 5.2.4.1. Product Testing & Sterilization Market, 2018 - 2030 (USD Million)
    • 5.2.5. Product Implementation
      • 5.2.5.1. Product Implementation Market, 2018 - 2030 (USD Million)
    • 5.2.6. Product Upgrade
      • 5.2.6.1. Product Upgrade Market, 2018 - 2030 (USD Million)
    • 5.2.7. Product Maintenance
      • 5.2.7.1. Product Maintenance Market, 2018 - 2030 (USD Million)
    • 5.2.8. Contract Manufacturing
      • 5.2.8.1. Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 6. Inhaled and Intranasal Products Contract Service Providers Market: Regional Analysis

  • 6.1. Inhaled and Intranasal Products Contract Service Providers: Regional market share analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.4. Italy
      • 6.3.4.1. Italy Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.6. Denmark
      • 6.3.6.1. Denmark Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.7. Sweden
      • 6.3.7.1. Sweden Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.8. Norway
      • 6.3.8.1. Norway Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.9. Rest of EU
      • 6.3.9.1. Rest of EU Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.3. India
      • 6.4.3.1. India Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Japan Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. South Korea Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.8. Rest of APAC
      • 6.4.8.1. Rest of APAC Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.5. Rest of LATAM
      • 6.5.5.1. Rest of LATAM Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.3. South Arabia
      • 6.6.3.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.6. Rest of MEA
      • 6.6.6.1. Rest of MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Inhaled and Intranasal Products Contract Service Providers: Company market share analysis, 2022 & 2030
  • 7.2. Company Profiles
    • 7.2.1. Lonza
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Service benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Catalent
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Service benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Kindeva Drug Delivery (Formerly 3M Drug Delivery Systems)
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Service benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Recipharma
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Service benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Quotient Services
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Service benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hovione
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Service benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Colep
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Service benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Beximo Pharmaceuticals
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Service benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. DPT Laboratories
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Service benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Orion
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Service benchmarking
      • 7.2.10.4. Strategic initiatives